surpass trial tirzepatide Efficacy and safety of monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 Efficacy of tirzepatide in phase
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





00243-1/asset/3e6344be-cfd8-4182-b471-5c447dcc78dd/main.assets/gr1_lrg.jpg)
























